Categories: EnergyTechIndustryLEDManufacturingMedtechProductProductionResearchSupplyTechnology
Our compact multi-state fusion reactors offer high particle flux and exceptional lifetime performance, unlocking a wide variety of critical medical, industrial, and research applications today.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.02.2025 | - | $5.6M | - |
Mentions in press and media 4
| Date | Title | Description |
| 23.06.2026 | Astral Systems Raises £23 Million To Accelerate Fusion-Produced Medical Isotopes | Astral Systems announced that it has raised £23 million in funding to accelerate the development of fusion-produced medical isotopes.
The funding will support Astral’s efforts to scale production, expand its team and facilities, and advance... |
| 23.06.2026 | Astral Systems Raises £23M in First Close of Series A Funding | Astral Systems, a Bristol, UK-based nuclear fusion technology company, raised £23M in first close of Series A funding.
The round was led by Mercia Ventures with participation from Tees River, Daphni, Blast Club, Speedinvest, Playfair and ot... |
| 06.02.2025 | Astral Systems secures £4.5M to bring nuclear breakthroughs to healthcare | Bristol-based Nuclear tech Astral Systems, a ambitious deeptech firm developing multistate fusion (MSF) technology, has raised £4.5M investment led by Speedinvest and Playfair, with the participation of angel investors including Oliver Buck... |
| - | Astral Systems | “Our compact multi-state fusion reactors offer high particle flux and exceptional lifetime performance, unlocking a wide variety of critical medical, industrial, and research applications today.” |
Reviews 0
